Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: On September 20, 2023, we issued 56,600 shares to settle a milestone contingent liability as part of our purchase of Heart & Lung Imaging Limited.
−Removed: The shares were ascribed a value of $1.6 million.
−Removed: The shares of common stock were issued without registration on the basis of the exemption for private placement provided by Section 4(a)(2) under the Securities Act.
−Removed: On July 7, 2023, we issued 113,303 shares to settle the stock holdback contingent liabilities as part of our purchase of Quantib B.V..
−Removed: The shares were ascribed a value of $3.5 million.
−Removed: The shares of common stock were issued without registration on the basis of the exemption for private placement provided by Section 4(a)(2) under the Securities Act.
−Removed: On April 30, 2023 we issued 114,227 shares to settle the General Holdback liabilities as part of our purchase of all the outstanding stock of Aidence Holding B.V..
+Added: On March 27, 2024, we issued 95,019 shares of common stock to settle a milestone contingent liability as part of our purchase of Heart & Lung Imaging Limited.
The shares were ascribed a value of $4.6 million.
−Removed: The shares of common stock were issued without registration on the basis of the exemption for private placement provided by Section 4(a)(2) under the Securities Act.
+Added: The shares were issued without registration on the basis of the exemption for private placements provided by Section 4(a)(2) under the Securities Act.
Defaults Upon Senior Securities
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.